Bardet-Biedl Syndrome Study: Clinical and Genetic Epidemiology Study in Adults

Overview

This study is based on the study of the natural history of a rare disorder: the Bardet-Biedl syndrome (BBS) (which is associated with retinitis pigmentosa, polydactyly, cognitive impairment, obesity, and kidney failure). The clinical, biological, and radiological features of adult patients are studied. In parallel, a molecular study is performed on the known genes to date (8 genes from BBS1 to BBS8) and to identify new genes involved. The parts of the study are combined in a phenotype-genotype correlation study.

Full Title of Study: “Bardet-Biedl Syndrome: Clinical and Genetic Epidemiology Study in the Adults”

Study Type

  • Study Type: Observational

Interventions

  • Behavioral: clinical, biological, and radiological

Clinical Trial Outcome Measures

Primary Measures

  • Outcome evaluated end 2005 and 2006
  • Clinical results (natural history, phenotype-genotype correlations, genetic epidemiology, new genes identification

Secondary Measures

  • This study may lead to further clinical investigations according to the results (new protocol to be established) and to further molecular investigations

Participating in This Clinical Trial

Inclusion Criteria

  • Adult (age over 16 years old)
  • At least 3 of the five major criteria (retinitis pigmentosa, obesity, polydactyly, cognitive impairment, and kidney disorder) and/or BBS mutations identified

Gender Eligibility: All

Minimum Age: 16 Years

Maximum Age: N/A

Investigator Details

  • Lead Sponsor
    • University Hospital, Strasbourg, France
  • Overall Official(s)
    • Hélène Dollfus, MD, Principal Investigator, Fédération Génétique
    • J-Louis Mandel, MD, Principal Investigator, IGBMC
    • Pascal Bousquet, MD, Principal Investigator, CIC Strasbourg
    • Christian Brandt, MD, Principal Investigator, CIC Strasbourg
    • Catherine Arnold, MD, Principal Investigator, CIC Strasbourg
    • Alain Verloes, MD, Principal Investigator, Unité de Génétique Robert Debré
    • Régis Hanfard, MD, Principal Investigator, CIC Robet Debré
    • Didier Lacombe, MD, Principal Investigator, Service de Génétique Médicale/Bordeaux
    • Virginie Bernard, MD, Principal Investigator, CIC Bordeaux
    • Sylvie Manouvrier, MD, Principal Investigator, Service de Génétique Médicale Lille

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.